190 related articles for article (PubMed ID: 24019393)
1. Equol-producing status, isoflavone intake, and breast density in a sample of U.S. Chinese women.
Tseng M; Byrne C; Kurzer MS; Fang CY
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1975-83. PubMed ID: 24019393
[TBL] [Abstract][Full Text] [Related]
2. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
Virk-Baker MK; Barnes S; Krontiras H; Nagy TR
Nutr Res; 2014 Feb; 34(2):116-25. PubMed ID: 24461312
[TBL] [Abstract][Full Text] [Related]
3. Equol status modifies the association of soy intake and mammographic density in a sample of postmenopausal women.
Fuhrman BJ; Teter BE; Barba M; Byrne C; Cavalleri A; Grant BJ; Horvath PJ; Morelli D; Venturelli E; Muti PC
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):33-42. PubMed ID: 18199709
[TBL] [Abstract][Full Text] [Related]
4. Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women.
Frankenfeld CL; McTiernan A; Aiello EJ; Thomas WK; LaCroix K; Schramm J; Schwartz SM; Holt VL; Lampe JW
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1156-62. PubMed ID: 15247126
[TBL] [Abstract][Full Text] [Related]
5. A cross-sectional study of equol producer status and self-reported vasomotor symptoms.
Newton KM; Reed SD; Uchiyama S; Qu C; Ueno T; Iwashita S; Gunderson G; Fuller S; Lampe JW
Menopause; 2015 May; 22(5):489-95. PubMed ID: 25380274
[TBL] [Abstract][Full Text] [Related]
6. Optimal cut-off value for equol-producing status in women: The Japan Nurses' Health Study urinary isoflavone concentration survey.
Ideno Y; Hayashi K; Nakajima-Shimada J; Onizuka Y; Kishi M; Ueno T; Uchiyama S
PLoS One; 2018; 13(7):e0201318. PubMed ID: 30048499
[TBL] [Abstract][Full Text] [Related]
7. Daidzein-metabolizing phenotypes in relation to mammographic breast density among premenopausal women in the United States.
Atkinson C; Newton KM; Aiello Bowles EJ; Lehman CD; Stanczyk FZ; Westerlind KC; Li L; Lampe JW
Breast Cancer Res Treat; 2009 Aug; 116(3):587-94. PubMed ID: 18821061
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of the equol-producer phenotype and its relationship with dietary isoflavone and serum lipids in healthy Chinese adults.
Liu B; Qin L; Liu A; Uchiyama S; Ueno T; Li X; Wang P
J Epidemiol; 2010; 20(5):377-84. PubMed ID: 20671375
[TBL] [Abstract][Full Text] [Related]
9. Effects of short-term fructooligosaccharide intake on equol production in Japanese postmenopausal women consuming soy isoflavone supplements: a pilot study.
Tousen Y; Uehara M; Abe F; Kimira Y; Ishimi Y
Nutr J; 2013 Sep; 12():127. PubMed ID: 24034304
[TBL] [Abstract][Full Text] [Related]
10. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010).
North American Menopause Society
Menopause; 2011 Jul; 18(7):732-53. PubMed ID: 21685820
[TBL] [Abstract][Full Text] [Related]
11. Being overweight or obese is associated with harboring a gut microbial community not capable of metabolizing the soy isoflavone daidzein to O-desmethylangolensin in peri- and post-menopausal women.
Miller LM; Lampe JW; Newton KM; Gundersen G; Fuller S; Reed SD; Frankenfeld CL
Maturitas; 2017 May; 99():37-42. PubMed ID: 28364866
[TBL] [Abstract][Full Text] [Related]
12. Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein.
Frankenfeld CL; Atkinson C; Wähälä K; Lampe JW
Eur J Clin Nutr; 2014 Apr; 68(4):526-30. PubMed ID: 24569543
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women.
Liu ZM; Ho SC; Woo J; Chen YM; Wong C
Menopause; 2014 Jun; 21(6):653-60. PubMed ID: 24149925
[TBL] [Abstract][Full Text] [Related]
14. Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial.
Wu J; Oka J; Ezaki J; Ohtomo T; Ueno T; Uchiyama S; Toda T; Uehara M; Ishimi Y
Menopause; 2007; 14(5):866-74. PubMed ID: 17464237
[TBL] [Abstract][Full Text] [Related]
15. Demographic, anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among premenopausal women in the United States.
Atkinson C; Newton KM; Bowles EJ; Yong M; Lampe JW
Am J Clin Nutr; 2008 Mar; 87(3):679-87. PubMed ID: 18326607
[TBL] [Abstract][Full Text] [Related]
16. Overnight urinary isoflavone excretion in a population of women living in the United States, and its relationship to isoflavone intake.
Atkinson C; Skor HE; Fitzgibbons ED; Scholes D; Chen C; Wähälä K; Schwartz SM; Lampe JW
Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):253-60. PubMed ID: 11895874
[TBL] [Abstract][Full Text] [Related]
17. Soya isoflavone consumption in relation to carotid intima-media thickness in Chinese equol excretors aged 40-65 years.
Cai Y; Guo K; Chen C; Wang P; Zhang B; Zhou Q; Mei F; Su Y
Br J Nutr; 2012 Nov; 108(9):1698-704. PubMed ID: 22373572
[TBL] [Abstract][Full Text] [Related]
18. Dietary equol and bone metabolism in postmenopausal Japanese women and osteoporotic mice.
Ishimi Y
J Nutr; 2010 Jul; 140(7):1373S-6S. PubMed ID: 20484547
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics reveals differences between three daidzein metabolizing phenotypes in adults with cardiometabolic risk factors.
Reverri EJ; Slupsky CM; Mishchuk DO; Steinberg FM
Mol Nutr Food Res; 2017 Jan; 61(1):. PubMed ID: 27364093
[TBL] [Abstract][Full Text] [Related]
20. Relationship of equol production between children aged 5-7 years and their mothers.
Wada K; Ueno T; Uchiyama S; Abiru Y; Tsuji M; Konishi K; Mizuta F; Goto Y; Tamura T; Shiraki M; Iwasa S; Nagata C
Eur J Nutr; 2017 Aug; 56(5):1911-1917. PubMed ID: 27256298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
